Preventive Vaccine Market

SKU: DMBT43 | Last Updated On: Aug 18 2022 | Available Formats

> Preventive Vaccine Market Expected to reach a high CAGR of 13.5% during the forecast period 2022-2029

Preventive Vaccine Market is segmented By Disease Indication (Pneumococcal Disease, DTP, Meningococcal Disease, MMR, Varicella, Influenza, Rotavirus, Polio, Human Papilloma Virus, Hepatitis, Dengue), By End-User (Adults, Pediatrics), By Route of Administration (Oral Administration, Intramuscular and Subcutaneous Administration, Other Routes of Administration), By Technology (Inactivated and Subunit Vaccines, Recombinant Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Preventive Vaccine Market Expected to reach a high CAGR of 13.5% By 2029: DataM Intelligence

Trending Topics

Glycomics and Glycobiology Market

Cell Signaling Market

Oncolytic Virus Therapy Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!